Prevalence of Antimicrobial Resistant of Vibrio parahaemolyticus Isolated from Diarrheal Patients — Six PLADs, China, 2016−2020

WHAT IS ALREADY KNOWN ON THIS TOPIC? Vibrio parahaemolyticus (V. parahaemolyticus) is frequently resistant to common antimicrobials such as ampicillin and generally highly susceptible to most clinically used antimicrobials. WHAT IS ADDED BY THIS REPORT? V. parahaemolyticus were highly resistant to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Haihong, Pires, Sara M., Ellis-Iversen, Johanne, Tang, Zhen, Zhang, Xiaoai, Liu, Jikai, Li, Weiwei, Cui, Qingpo, Zou, Jing, Fu, Ping, Guo, Yunchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2021
Materias:
Preplanned Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393055/
https://www.ncbi.nlm.nih.gov/pubmed/34594947
http://dx.doi.org/10.46234/ccdcw2021.135
_version_ 1783743645413801984
author Han, Haihong
Pires, Sara M.
Ellis-Iversen, Johanne
Tang, Zhen
Zhang, Xiaoai
Liu, Jikai
Li, Weiwei
Cui, Qingpo
Zou, Jing
Fu, Ping
Guo, Yunchang
author_facet Han, Haihong
Pires, Sara M.
Ellis-Iversen, Johanne
Tang, Zhen
Zhang, Xiaoai
Liu, Jikai
Li, Weiwei
Cui, Qingpo
Zou, Jing
Fu, Ping
Guo, Yunchang
author_sort Han, Haihong
collection PubMed
description WHAT IS ALREADY KNOWN ON THIS TOPIC? Vibrio parahaemolyticus (V. parahaemolyticus) is frequently resistant to common antimicrobials such as ampicillin and generally highly susceptible to most clinically used antimicrobials. WHAT IS ADDED BY THIS REPORT? V. parahaemolyticus were highly resistant to cefazolin and ampicillin: 94.4% and 37.0%, respectively. However, it was below 3% resistance to all 10 other antimicrobials including clinically relevant agents and even imipenem. The overall levels of antimicrobial resistance and multidrug resistance were 95.1% and 3.3%, respectively. The distribution of antimicrobial resistance and the multidrug resistance had regional, temporal, sexual, and isolated source strain variation. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? This study provides data on drug resistance of V. parahaemolyticus in Chinese clinical settings, which will help develop a public health strategy.
format Online
Article
Text
id pubmed-8393055
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-83930552021-09-29 Prevalence of Antimicrobial Resistant of Vibrio parahaemolyticus Isolated from Diarrheal Patients — Six PLADs, China, 2016−2020 Han, Haihong Pires, Sara M. Ellis-Iversen, Johanne Tang, Zhen Zhang, Xiaoai Liu, Jikai Li, Weiwei Cui, Qingpo Zou, Jing Fu, Ping Guo, Yunchang China CDC Wkly Preplanned Studies WHAT IS ALREADY KNOWN ON THIS TOPIC? Vibrio parahaemolyticus (V. parahaemolyticus) is frequently resistant to common antimicrobials such as ampicillin and generally highly susceptible to most clinically used antimicrobials. WHAT IS ADDED BY THIS REPORT? V. parahaemolyticus were highly resistant to cefazolin and ampicillin: 94.4% and 37.0%, respectively. However, it was below 3% resistance to all 10 other antimicrobials including clinically relevant agents and even imipenem. The overall levels of antimicrobial resistance and multidrug resistance were 95.1% and 3.3%, respectively. The distribution of antimicrobial resistance and the multidrug resistance had regional, temporal, sexual, and isolated source strain variation. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? This study provides data on drug resistance of V. parahaemolyticus in Chinese clinical settings, which will help develop a public health strategy. Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2021-07-16 /pmc/articles/PMC8393055/ /pubmed/34594947 http://dx.doi.org/10.46234/ccdcw2021.135 Text en Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2021 https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Preplanned Studies
Han, Haihong
Pires, Sara M.
Ellis-Iversen, Johanne
Tang, Zhen
Zhang, Xiaoai
Liu, Jikai
Li, Weiwei
Cui, Qingpo
Zou, Jing
Fu, Ping
Guo, Yunchang
Prevalence of Antimicrobial Resistant of Vibrio parahaemolyticus Isolated from Diarrheal Patients — Six PLADs, China, 2016−2020
title Prevalence of Antimicrobial Resistant of Vibrio parahaemolyticus Isolated from Diarrheal Patients — Six PLADs, China, 2016−2020
title_full Prevalence of Antimicrobial Resistant of Vibrio parahaemolyticus Isolated from Diarrheal Patients — Six PLADs, China, 2016−2020
title_fullStr Prevalence of Antimicrobial Resistant of Vibrio parahaemolyticus Isolated from Diarrheal Patients — Six PLADs, China, 2016−2020
title_full_unstemmed Prevalence of Antimicrobial Resistant of Vibrio parahaemolyticus Isolated from Diarrheal Patients — Six PLADs, China, 2016−2020
title_short Prevalence of Antimicrobial Resistant of Vibrio parahaemolyticus Isolated from Diarrheal Patients — Six PLADs, China, 2016−2020
title_sort prevalence of antimicrobial resistant of vibrio parahaemolyticus isolated from diarrheal patients — six plads, china, 2016−2020
topic Preplanned Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393055/
https://www.ncbi.nlm.nih.gov/pubmed/34594947
http://dx.doi.org/10.46234/ccdcw2021.135
work_keys_str_mv AT hanhaihong prevalenceofantimicrobialresistantofvibrioparahaemolyticusisolatedfromdiarrhealpatientssixpladschina20162020
AT piressaram prevalenceofantimicrobialresistantofvibrioparahaemolyticusisolatedfromdiarrhealpatientssixpladschina20162020
AT ellisiversenjohanne prevalenceofantimicrobialresistantofvibrioparahaemolyticusisolatedfromdiarrhealpatientssixpladschina20162020
AT tangzhen prevalenceofantimicrobialresistantofvibrioparahaemolyticusisolatedfromdiarrhealpatientssixpladschina20162020
AT zhangxiaoai prevalenceofantimicrobialresistantofvibrioparahaemolyticusisolatedfromdiarrhealpatientssixpladschina20162020
AT liujikai prevalenceofantimicrobialresistantofvibrioparahaemolyticusisolatedfromdiarrhealpatientssixpladschina20162020
AT liweiwei prevalenceofantimicrobialresistantofvibrioparahaemolyticusisolatedfromdiarrhealpatientssixpladschina20162020
AT cuiqingpo prevalenceofantimicrobialresistantofvibrioparahaemolyticusisolatedfromdiarrhealpatientssixpladschina20162020
AT zoujing prevalenceofantimicrobialresistantofvibrioparahaemolyticusisolatedfromdiarrhealpatientssixpladschina20162020
AT fuping prevalenceofantimicrobialresistantofvibrioparahaemolyticusisolatedfromdiarrhealpatientssixpladschina20162020
AT guoyunchang prevalenceofantimicrobialresistantofvibrioparahaemolyticusisolatedfromdiarrhealpatientssixpladschina20162020

Ejemplares similares